Andere Sprachen GSK plc

Aktien

Realtime-Estimate Cboe Europe Andere Börsenplätze 15:16:29 31.05.2024			% 5 Tage	% 1. Jan.
1’752 ^GBX	+1.29%		-1.01%	+21.12%

30.05.	GSK PLC : Goldman Sachs ist jetzt neutral	ZM
30.05.	GSK PLC : Goldman Sachs gibt eine neutrale Bewertung ab	ZM

GSK PLC : Goldman Sachs moins optimiste	30.05.
GSK PLC : Goldman Sachs confirme sa recommandation neutre	30.05.
Jefferies and UBS cut Anglo American	30.05.
Dr Martens cuts payout as profit plummets	30.05.
Goldman startet GSK mit 'Neutral' - Ziel 1850 Pence	30.05.
US nears deal to fund Moderna's bird flu vaccine trial, FT reports	30.05.
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Wednesday Trading	29.05.
US, European nations consider vaccinating workers exposed to bird flu	27.05.
British Stocks Extend Losing Streak Amid Retail Sales Slump	24.05.
FTSE 100 falls; retail sales plunge in April	24.05.
GSK celebrates Illinois jury verdict in Valadez case	24.05.
GSK to Continue Vigorous Defense of Zantac Cancer Claims After Recent US Victory	24.05.
UK retail sales fall amid wet April; Co-Op Bank deal	24.05.
Jury spricht GSK in Zantac-Klage von Haftbarkeit frei	24.05.
GSK, Boehringer Ingelheim Bag Win in Zantac Cancer Case US Trial	24.05.
Sector Update: Health Care Stocks Retreat Late Afternoon	23.05.
Sector Update: Health Care	23.05.
GSK's Zantac Didn't Cause Woman's Cancer, Chicago Jury Verdict Says	23.05.
GSK's Zantac Cleared in Chicago Jury Trial for Alleged Colon Cancer Link	23.05.
GSK on Zantac Litigation Says Will Continue To "Vigorously Defend" Itself Against All Claims	23.05.

Keine Ergebnisse zu dieser Suche

GSK PLC : Ermutigender Start ins Jahr 2024; Prognose angehoben

Am 01. Mai 2024 um 17:38 Uhr